KBCols Sciences Pvt. Ltd. (Official Account)’s Post

🚀💚 𝐄𝐯𝐞𝐫 𝐡𝐚𝐝 𝐚𝐧 𝐢𝐝𝐞𝐚 𝐬𝐨 𝐢𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐢𝐭´𝐬 𝐰𝐨𝐫𝐭𝐡 €7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧?  💸 I’m incredibly proud to be part of the #XOLife journey and the visionary idea of Dr. Friderike Bruchmann to revolutionise our #healthcaresystem in Germany. Securing €7 million in funding is not just a milestone for the company, it’s a deeply personal achievement for me as it marks the first time in my career that I’ve had the privilege of managing an A financing round. 𝐁𝐮𝐭 𝐥𝐞𝐭’𝐬 𝐛𝐞 𝐜𝐥𝐞𝐚𝐫 - 𝐭𝐡𝐢𝐬 €7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐬 𝐣𝐮𝐬𝐭 𝐭𝐡𝐞 𝐛𝐞𝐠𝐢𝐧𝐧𝐢𝐧𝐠! 🚀 For the second time in my still young career, I’m part of a startup that has the potential - and the drive - to 𝐛𝐫𝐞𝐚𝐤 𝐭𝐡𝐞 €100 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐦𝐚𝐫𝐤 within a few years. The energy, the vision, and the relentless pursuit of innovation here at #XOLife are unlike anything I’ve experienced before. 🙏 𝐀 𝐇𝐞𝐚𝐫𝐭𝐟𝐞𝐥𝐭 𝐓𝐡𝐚𝐧𝐤 𝐘𝐨𝐮 To our incredible team - 30 𝐩𝐞𝐨𝐩𝐥𝐞, 13 𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥𝐢𝐭𝐢𝐞𝐬 - this may sound unimaginable to some companies, but for me, it’s the only way to truly innovate and push boundaries. Diversity isn’t just a buzzword; it’s a must-have when you’re working on something with the potential for international success. It’s how “𝐭𝐡𝐢𝐧𝐤𝐢𝐧𝐠 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐭𝐡𝐞 𝐛𝐨𝐱” becomes a reality. 🌍 🌟 𝐀 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐚𝐜𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐭𝐡𝐞 𝐮𝐧𝐬𝐮𝐧𝐠 𝐡𝐞𝐫𝐨𝐞𝐬 𝐨𝐟 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦, whose commitment, creativity, and positivity behind the scenes drive us forward every single day: Gabriela S., Yasemin Çetik, Avinash N., Hien Nguyen, Sarah Liewehr, Maksym Radishevskyi, Nitish Juttu and Schirin Yazgan! 🔧 𝐌𝐲 𝐍𝐞𝐱𝐭 𝐒𝐭𝐞𝐩𝐬 Now, the real work begins. I’m focused on developing marketing structures that will take the ImpactMonitor™ platform to the next level. From a complete overhaul of our website - aiming to place it in the top 1% of SEO rankings - to creating scalability and driving product development, 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐢𝐬 𝐚𝐥𝐥 𝐚𝐛𝐨𝐮𝐭 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠, 𝐨𝐩𝐭𝐢𝐦𝐢𝐬𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐞𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠. This journey is just getting started, and I’m thrilled to be part of it. 𝐋𝐞𝐭’𝐬 𝐤𝐞𝐞𝐩 𝐩𝐮𝐬𝐡𝐢𝐧𝐠 𝐛𝐨𝐮𝐧𝐝𝐚𝐫𝐢𝐞𝐬, 𝐬𝐞𝐭𝐭𝐢𝐧𝐠 𝐫𝐞𝐜𝐨𝐫𝐝𝐬, 𝐚𝐧𝐝 𝐦𝐚𝐤𝐢𝐧𝐠 𝐚𝐧 𝐢𝐦𝐩𝐚𝐜𝐭! 😎 #StartupLife #SeriesA #DigitalHealth #ImpactMonitor #InternationalExpansion #MarketingStrategy #SEO #Innovation #HealthcareRevolution #ProudToBePartOfThis

Vi Partners is proud to be investing in the 7𝐦€ round of German #Healthtech startup XO Life, together with Sandwater, Grazia Equity and Bayern Kapital, and existing investors. We are delighted to support Founder & CEO Dr. Friderike Bruchmann and her team to boost the expansion of XO Life's #𝐈𝐦𝐩𝐚𝐜𝐭𝐌𝐨𝐧𝐢𝐭𝐨𝐫 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦. XO Life is a #healthtech company that connects patients, experts, and pharmaceutical companies through its digital platform ImpactMonitor™. This platform offers a one-stop solution for digital product and treatment support, enabling pharmaceutical and medical device manufacturers to provide personalized and expert-driven guidance to patients. It also allows companies to gather real-world patient insights and streamline pharmacovigilance processes. The goal is to improve patient outcomes through better information, support, and engagement. Arnd Kaltofen-Ehmann, Partner at Vi Partners "The combination of sound medical information and an intuitive platform is tailored to today's patient needs. In addition, the Impact-Monitor™️ platform provides physicians, medical institutions and companies with valuable insights into the needs and preferences of users and can thus support the development of new, patient-oriented therapies." https://lnkd.in/eiXGBcEi

More interesting thoughts from Darwin Ling in the Bullpen Inning 1.

The key of the Change

🚀 Applications for Cohort V of the Innovators Club, our FREE 10-week network accelerator programme, are open NOW! Since launching in 2020, we've run one Innovators Club programme each year, welcoming a total of 20 life science start-ups across four cohorts. We're incredibly proud of the outstanding progress our Innovators Club alumni have gone on to achieve with just some of many highlights including: ⚡ Phycobloom and Phase Biolabs being selected to join the Breakthrough Energy Fellowship, with backing from Bill Gates 🤝 CC Bio being acquired by Precisio Biotix Therapeutics 🐶 Zonova being selected to join Zoetis' Veterinary Health Innovation Engine 🏆 Countless national and international awards and recognitions 💸 One stat we love to share is that our alumni have collectively raised over £62m in equity funding once they completed their respective programmes. A huge testament to the meaningful innovations each of our companies are developing from revolutionising human health to solving the climate crisis and everything in between. 👩🔬 We're also very proud of the fact that 45% of our alumni companies are women-led with at least one female founder or co-founder. 🔎 We're now on the lookout for the next cohort of stellar early-stage life science innovators. Could this be you? ⏰ Applications for Cohort V close on August 2nd! Find out more about the programme and how to apply here 👉 https://lnkd.in/efakJZV Innovators Club Cohort V, powered by Gold sponsor Marks & Clerk. If you're interesting in supporting Cohort V as a sponsor, drop Matthew McCann a message! #InnovatorsClub #innovation #accelerator #lifesciences

Tech Due-Diligence: mitigating risk when investing in digital innovations I got to exchange experiences and thoughts about how to better manage innovation and all its stakeholders. I took the opportunity to explain how LEVELS as an efficient and quality oriented digital tech provider and studio can help investors mitigate the investment risk. With experience of developing, building and supporting solutions a natural tech due-diligence provider emerges for a demanding investment community. The investor gets not just a second opinion about the technology of the company they are screening but an actual understanding and higher comprehension of what it takes to bring the venture to success.

Vinod Khosla, founder of Sun Microsystems and Khosla Ventures “It’s better to try and fail, than fail to try”. Many times we are asked about the challenges of innovating in biotech from Patagonia and why we do it. There are many advantages of being in a place were talent wants to live, but beyond that, we know that turning Patagonia into a biotech powerhouse, can structurally change the society and living standards of our region. When so much good can be created, we rather try and fail, than fail to try. Kura Biotech Blikka Genomics by Kura Biotech SynBioBeta #PatagoniaBiotechHUB

🌟 Meet Our Team: Netra Kumaresan🌟 In our beloved 'Meet the Team' series, we're thrilled to feature a valued member who's witnessed and contributed to the significant growth of AIM Biotech – a testament to the passion and drive that fuels our research. 🔬 From exploring the realms of angiogenesis and vasculogenesis to advancing our blood-brain barrier (BBB) models, Netra played a pivotal role in integrating automation to enhance our research capabilities. Celebrating the evolution from validation to impactful service projects, her journey is one of continuous learning and accomplishment. 🎓 Starting as an ambitious graduate and now a seasoned Senior Research Officer, her story reflects the essence of our team at AIM: dynamic, dedicated, and united in purpose. Join us in celebrating her achievements and the collaborative spirit that drives innovation at AIM. It's the unique talents and dedication of individuals like Netra that keep us at the cutting edge of biotechnological advancements. #AIMBiotech #MeetTheTeam #ResearchInnovation #CareerGrowth #BloodBrainBarrier #BiotechCareers

Let's connect at #bio2024 and talk #clinicaltrials #patientexperience #patientengagement #patientreportedoutcomes

The longevity market focused on extending the human lifespan and improving health in later years, is rapidly expanding. The sector attracts significant investments from VCs, the pharmaceutical industry and tech giants, aiming to revolutionize the way we approach aging and age-related diseases. It is great to see more longevity-focused events appearing on the conference scene - meeting to discuss, share knowledge and network is crucial for all of us. In a few weeks, during London Tech Week on June 10-11, LongeVC managing partner Sergey Jakimov will attend one of the panels during the Founders Longevity Forum. The event, co-organized in partnership with Longevity.Technology, will gather some of the industry’s greatest leaders, including Insilico Medicine CEO and Head of LongeVC Advisory Board Alex Zhavoronkov, Bruno Balen, founder of Ani Biome, one of LongeVC portfolio companies, Todd White (VitaDAO), Aubrey de Grey (Longevity Escape Velocity (LEV) Foundation), Petr Sramek (LongevityTech.fund), Bhuvan Srinivasan (Ultrahuman), Christin Glorioso, MD PHD (NeuroAge Therapeutics), Joanna Bensz (Longevity Center Europe) and more. If you’d like to connect with Sergey Jakimov or Garri Zmudze during the event, drop them a message or contact us via hq@longevc.com. https://lnkd.in/d3cDSEe6 #Longevity #BiotechInvesting #FoundersForum #London Founders Forum Group Carolyn Dawson